Print

Print


this is the company Trauti was telling us abut that  finds a 90% cure rate  for Hep C is not profitable  enough  because cures reduce the pool of  patients: See Salary, Bonus, and Pay details for Jobs at GILD Key Executive Compensation  GILD  Name/Title   2013 2014 2015 2016 2017 
            
            
     Key Executive Compensation  36,942,979 40,236,769 39,542,957 41,254,789 40,646,037 
            
     John F. Milligan/President and Chief Executive Officer  6,566,287 8,261,096 8,276,701 13,935,212 15,438,459 
            
     Robin L. Washington/Executive Vice President and Chief Financial Officer  3,941,728 6,223,492 5,557,233 5,068,062 5,529,346 
            
     John C. Martin/Executive Chairman  15,451,862 18,957,994 18,755,952 10,442,372 7,311,180 
            
     Kevin Young/Chief Operating Officer  5,394,714 - - 5,639,674 6,221,742 
            
     Norbert W. Bischofberger/Executive Vice President Research and Development and Chief Scientific Officer  5,588,388 6,794,187 6,953,071 6,169,469 6,145,310 
A publicly-traded company is only required to discl
Ray
Rayilyn Brown
Past Director AZNPF
Arizona Chapter National Parkinson Foundation

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn